retatrutide trial phase results news today New 3 data just dropped 👀 Eli Lilly's reported average Here we go! The first

A class-action complaint filed in November 2025 against OpenLoop Health and Triad Rx - the medical group infrastructure and pharmacy involved in a separate telehealth platform - alleges that compounded oral tirzepatide tablets have no viable absorption pathway and therefore cannot produce a therapeutic effect

No weight loss strategy can preferentially target one type of fat deposit

And I'm a big fan of that because as a clinician you need some guide, some efficient and effective way to treat the patient in front of you

Adipokines as an important link between hidradenitis suppurativa and obesity: a narrative review